凝血酶冻干粉联合质子泵抑制剂治疗消化性溃疡出血的临床效果

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Thrombin Freeze-dried Powder combined with proton pump inhibitor in treatment of peptic ulcer hemorrhage.Methods A total of 60 patients with peptic ulcer hemorrhage admitted to the First People′s Hospital of Ji′an City from January 2018 to January 2019 were selected as the research objects,and they were divided into the control group and the experimental group according to the method of dynamic random grouping,with 30 cases in each group.The control group was treated with proton pump inhibitor,and the experimental group was treated with Thrombin Freeze-dried Powder combined with proton pump inhibitor.The clinical efficacy,coagulation indexes,platelet parameters and adverse reactions were compared between the two groups.Results The total effective rate of the experimental group was higher than that of the control group,and the difference was statistically significant(P＜0.05).There were no statistically significant differences in plasma prothrombin time(PT),international normalized ratio(INR),activated partial thromboplastin time(APTT),thrombin time(TT),fibrinogen content(Fg),platelet count(BPC),platelet specific volume(PCT)and mean blood platelet volume(MPV)between the two groups before treatment(P＞0.05).The PT,INR,APTT,TT,MPV of the two groups after treatment were lower than those before treatment,the FG,BPC and PCT of the two groups after treatment were higher than those before treatment,and the differences were statistically significant(P＜0.05).After treatment,the PT,INR,APTT,TT,MPV in the experimental group were lower than those in the control group,the Fg,BPC and PCT in the experimental group were higher than those in the control group,and the differences were statistically significant(P＜0.05).The total incidence of adverse reactions in the experimental group was lower than that in the control group,and the difference was statistically significant(P＜0.05).Conclusion Thrombin freeze-dried powder combined with proton pump inhibitor has a significant effect treating peptic ulcer hemorrhage.

Key words： Peptic ulcer hemorrhage Thrombin Freezedried Powder Proton pump inhibitors Omeprazole Clinical efficacy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HU Qing-fang

Cite this article:

HU Qing-fang. Clinical effect of Thrombin Freeze-dried Powder combined with proton pump inhibitor in treatment of peptic ulcer hemorrhage[J]. 中国当代医药, 2021, 28(14): 50-53.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I14/50

[1]	杜小芳，朱兴华.凝血酶冻干粉治疗消化性溃疡出血的疗效及血小板参数变化[J].现代消化及介入诊疗，2019，24（8）：847-850.
[2]	刘改莉.奥美拉唑联合凝血酶治疗慢性胃炎合并消化性溃疡出血的临床效果[J].临床医学研究与实践，2020，5（7）：54-55.
[3]	张昭君.134例消化性溃疡合并上消化道出血患者应用奥美拉唑的临床情况分析[J].中国医学创新，2020，17（28）：161-165.
[4]	陈克科.康复新液、凝血酶冻干粉与奥美拉唑联用方案治疗消化性溃疡出血的临床效果评价[J].中国疗养医学，2017，26（12）：1317-1318.
[5]	邓伟婧，刘丽阳，白云飞，等.注射用艾司奥美拉唑钠联合生长抑素和凝血酶治疗消化性溃疡出血的疗效观察[J].中国医学前沿杂志（电子版），2017，9（7）：178-181.
[6]	张彦，陈龙.胃镜下肾上腺素与凝血酶联合治疗消化性溃疡合并出血疗效研究[J].陕西医学杂志，2019，48（2）：259-261.
[7]	付国文.奥美拉唑联合凝血酶治疗慢性胃炎合并消化性溃疡出血患者的临床效果和安全性[J].医疗装备，2017，30（23）：147-148.
[8]	王学花.奥美拉唑联合凝血酶治疗慢性胃炎合并消化性溃疡出血患者的临床效果探讨[J].心理月刊，2019，14（1）：167.
[9]	杨曦.消化性溃疡出血行注射用埃索美拉唑联合凝血酶的临床疗效研究[J].中国处方药，2019，17（8）：100-101.
[10]	张咏华，李玲，周佳美，等.康复新液、凝血酶冻干粉联合奥美拉唑治疗消化性溃疡出血的临床疗效及纤维蛋白原变化分析[J].现代消化及介入诊疗，2016，21（2）：222-224.
[11]	吴大春.慢性胃炎并消化性溃疡出血应用凝血酶联合奥美拉唑治疗的效果观察[J].中外医学研究，2018，16（10）：16-17.
[12]	刘小娟.大剂量奥美拉唑治疗消化性溃疡出血的有效性与安全性[J].医学信息，2020，33（17）：143-145.
[13]	郝金海.不同剂量奥美拉唑联合内镜下止血治疗中低危消化性溃疡出血的效果比较[J].河南医学研究，2019，28（15）：2741-2742.
[14]	邹会.胃镜下肾上腺素联合凝血酶治疗消化性溃疡合并出血的临床效果[J].中国当代医药，2017，24（21）：21-23.
[15]	蔡卫东，邓素贞，谭子爵.生长抑素治疗非静脉曲张性上消化道出血的有效性[J].中国医药科学，2019，9（22）：59-61，65.
[16]	周仁正，谢发平，陈璐.肝硬化合并上消化道出血患者的危险因素分析[J].临床和实验医学杂志，2019，18（12）：1280-1283.